The 130th Executive Board meeting (EB130) from 16-23 Jan, 2012


1. Opening of the session and adoption of the agenda
2. Report by the Director-General
3. Nomination of the Director-General

3.1 Nomination for the post
3.2 Draft contract

4. Report of the Programme, Budget and Administration Committee of the Executive Board
5. WHO reform

6. Technical and health matters

6.1 Prevention and control of noncommunicable diseases
Outcomes of the High-level Meeting of the General Assembly on the Prevention and Control of Noncommunicable Diseases and the First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control
Implementation of the global strategy for the prevention and control of noncommunicable diseases and the action plan
Implementation of the action plan for the prevention of avoidable blindness and visual impairment
6.2 Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level
6.3 Nutrition
Infant and young child nutrition
Nutrition of women in the preconception period, during pregnancy and the breastfeeding period
6.4 Early marriages, adolescent and young pregnancies
6.5 Monitoring of the achievement of the health-related Millennium Development Goals
• Progress in the achievement of the health-related Millennium Development Goals
• Global health goals after 2015
• Implementation of the recommendations of the Commission on Information and Accountability for Women’s and Children’s Health
6.6 Social determinants of health: outcome of the World Conference on Social Determinants of Health (Rio de Janeiro, Brazil, October 2011)
6.7 Implementation of the International Health Regulations (2005)
6.8 Global mass gatherings: implications and opportunities for global health security
6.9 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report on the work of the Advisory Group
6.10 Poliomyelitis: intensification of the global eradication initiative
6.11 Elimination of schistosomiasis
6.12 Draft global vaccine action plan: update
6.13 Substandard/spurious/falsely-labelled/falsified/counterfeit medical products: report of the Working Group of Member States
6.14 Consultative expert working group on research and development: financing and coordination
6.15 WHO’s response, and role as the health cluster lead, in meeting the growing demands of health in humanitarian emergencies

7. Financial matters

7.1 Amendments to the Financial Regulations and Financial Rules [if any]

8. Staffing matters

8.1 Appointment of the Regional Director for the Eastern Mediterranean
8.2 Human resources: annual report
8.3 Report of the International Civil Service Commission
8.4 Statement by the representative of the WHO staff associations
8.5 Amendments to the Staff Regulations and Staff Rules

9. Management matters

9.1 Election of the Director-General of the World Health Organization: report of the working group
9.2 Membership of the Independent Expert Oversight Advisory Committee
9.3 Reports of committees of the Executive Board • Standing Committee on Nongovernmental Organizations • Foundations and awards
9.4 Provisional agenda of the Sixty-fifth World Health Assembly and date and place of the 131st session of the Executive Board

10. Matters for information

10.1 Reports of advisory bodies

• Expert committees and study groups

10.2 Progress reports

Health systems and research
A. Health system strengthening (resolutions WHA64.9, WHA64.8, WHA63.27, WHA62.12 and WHA60.27)
B. WHO’s role and responsibilities in health research (resolution WHA63.21)
C. Global strategy and plan of action on public health, innovation and intellectual property (resolution WHA61.21)
Disease eradication, prevention and control
D. Smallpox eradication: destruction of variola virus stocks (resolution WHA60.1)
E. Eradication of dracunculiasis (resolution WHA64.16)
F. Chagas disease: control and elimination (resolution WHA63.20)
G. Viral hepatitis (resolution WHA63.18)
H. Prevention and control of multidrug-resistant tuberculosis and extensively drugresistant tuberculosis (resolution WHA62.15)
I. Cholera: mechanisms for control and prevention (resolution WHA64.15) J. Control of human African trypanosomiasis (resolution WHA57.2)
K. Global health sector strategy on HIV/AIDS, 2011–2015 (resolution WHA64.14)
L. Prevention and control of sexually transmitted infections: global strategy (resolution WHA59.19)
M. Reproductive health: strategy to accelerate progress towards the attainment of international development goals and targets (resolution WHA57.12)
N. Advancing food safety initiatives (resolution WHA63.3)
O. Climate change and health (resolutions EB124.R5 and WHA61.19)
P. Partnerships (resolution WHA63.10)
11. Closure of the session
final PHM Comments_EB130_Jan2012.pdf283.06 KB
WHO EB 130 - MMI statement on agenda item 6-6 SDH.pdf59.26 KB
WHO EB 130 - MMI statement on agenda item 5 WHO Reform_Managerial reform.pdf53.89 KB
Statement_Priority setting_MMI_PHM.pdf65.61 KB
WHO EB 130-MMI PHM statement on NCDs.pdf69.39 KB
EB 130 WCC PHM statement on Substandard-Falsely-labelled, Falsified-Counterfeit Medicines.pdf34.14 KB
WHO EB 130 - MMI PHM Statement on Agenda item 6-12 vaccine action plan.pdf88.98 KB
WHO EB130- MMI statement Rio + 20.pdf97.57 KB
WHO EB 130 - PHM statement on smallpox_Agenda Item 10.pdf30.71 KB
EB 130_day 1_Notes.pdf65.33 KB
EB 130_Day_2_Notes.pdf78.78 KB
EB130_day_3_Notes.pdf50.04 KB
EB 130_Day _4_Notes.pdf75.58 KB
EB130_Day_5_Notes.pdf61.69 KB
EB130_day_6_Notes.pdf66.79 KB
EB130_Day_7_Notes.pdf61.23 KB